FDA Inspection
AltaSciences Clinical Los Angeles Inc.AltaSciences Clinical Los Angeles Inc. – FDA Inspection, Jun 30, 2022
Record Details
This FDA Inspection record concerns AltaSciences Clinical Los Angeles Inc., with an inspection on June 30, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 30, 2022
- Product Type
- Drugs
View Company Profile
ID · 14797777-2498-4b83-808f-13fa2eb9406e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1174519
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of AltaSciences Clinical Los Angeles Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 18, 2021 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 4, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 24, 2017 | Not classified | Los Angeles District Office | |
| March 24, 2017 | Not classified | Los Angeles District Office | |
| March 24, 2017 | Not classified | Los Angeles District Office |
Other documents for AltaSciences Clinical Los Angeles Inc.
- FDA Inspection 1144217 - 2021-06-18
- FDA Inspection 1102096 - 2019-09-04
- FDA Inspection 1008799 - 2017-03-24
- FDA Inspection 1008784 - 2017-03-24
- FDA Inspection 1006299 - 2017-03-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.